Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001 Meeting Abstract
| Authors: | Garon, E. B.; Hellmann, M. D.; Costa, E. C.; Leighl, N. B.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; Patnaik, A.; Gubens, M. A.; Ramalingam, S. S.; Felip, E.; Scalzo, C.; Jensen, E.; Kush, D. A.; Hui, R. |
| Abstract Title: | Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001 |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-06-20 |
| Language: | English |
| ACCESSION: | WOS:000489109800013 |
| DOI: | 10.1200/JCO.2019.37.18_suppl.LBA9015 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA9015 -- Source: Wos |
